Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

THMO - ThermoGenesis Holdings, Inc.

Previous close
0.3102
0.310   100.000%

Share volume: 0
Last Updated: Fri 14 Jun 2024 08:05:14 PM CEST
Surgical and Medical Instrument Manufacturing : -0.06%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
20%
Profitability 25%
Dept financing 25%
Liquidity 15%
Performance 15%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
-40.74%
6 Months
-27.27%
1 Year
-72.08%
2 Year
-94.39%
Key data
Stock price
$0.31
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
-$4.82
52 WEEK RANGE
$0.13 - $1.25
52 WEEK CHANGE
-$73.38
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
7.953 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Xiao C. Xu
Region: US
Website: thermogenesis.com
Employees: 40
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology.

Recent news